News for Sansure Biotech Inc. (688289.SS)

Sansure Biotech Inc (“Sansure”) is a US$1.4bn market capitalisation in vitro diagnostic solutions company listed on Shanghai Stock Exchange Mpox virus...

VANCOUVER, BC, April 5, 2024 /PRNewswire/ - Asep Medical Holdings Inc. is very pleased to announce that its joint venture company with leading Chinese biotech company Sansure Biotech Inc. ,...

The global point of care diagnostics market growth is attributed to the rise in the prevalence of chronic diseases and several helpful initiatives...

/PRNewswire/ -- In the near future, the CT/NG (Chlamydia and Gonorrhea) testing industry is poised to witness significant advancements and transformations....

/PRNewswire/ -- The "Cervical Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation,...

/PRNewswire/ -- The "Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Technology, Therapeutic Area,...

VANCOUVER, BC, Jan. 27, 2023 /PRNewswire/ - Asep Medical Holdings Inc. is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company,... | January 28, 2023

The global cervical dysplasia market size was valued at USD 584.86 million in 2021 and is expected to surpass USD 974.11 million by 2028, registering a...

/PRNewswire/ -- The "HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), PAP Test), End User...